Our Companies

“The best way to predict the future is to invent it.”
— Alan Kay

AI. Innovation. Impact.

We believe that AI is not just a tool—it’s a transformative force that, when combined with human expertise, has the power to revolutionize healthcare on a global scale.

We are driven daily to push the boundaries of innovation in biomedical signal processing and AI-driven diagnostics to make life-saving insights more accessible, precise, and actionable.

From turning ECG waveforms into rich, quantifiable datasets to enabling real-time, AI-powered cardiovascular monitoring, we are redefining how biometric intelligence is used to prevent and manage disease.

But technology alone isn’t enough—true impact comes from responsible innovation.

That’s why we are committed to ethical AI, ensuring that our advancements not only improve clinical outcomes but also democratize healthcare, bridging gaps in access and empowering individuals to take control of their heart health.

With a global vision and a relentless drive to innovate, we are shaping the future where AI, healthcare, and human well-being converge to create smarter, more proactive, and more equitable medical solutions.

Device-Agnostic ECG Signal Processing

What We Do
At its core, MaxYield is a cutting-edge Signal Processing Neural Network designed to extract true signals from even the noisiest recordings.

With MaxYield, we transform any ECG waveform into a precise, data-rich spreadsheet, unlocking the full constellation of insights hidden within each heartbeat—and this is just the beginning.

We call this a Neuralized ECG and in seconds we can:
● Identify and isolate the true signal from any ECG device, and
● Convert these complex waveforms to a quantified set of quantified ECG tables
● Our quantified ECG tables can be used to identify Events and support Conditions for Diagnosis

Why It Matters
ECGs are the cornerstone of Cardiovascular Disease (CVD) detection and management, used globally across hospitals, clinics, and personal health devices.
 
● Fast, non-invasive, cost-effective heart diagnostics
● Detects arrhythmias, ischemia, and early warning signs
● Essential for monitoring disease progression and treatment response

Whether it is one heartbeat or a million heart beats, we reduce hours, days and weeks of semi-manual labour to seconds or  minutes for ECG labeling and Event analysis.

Learn more and visit TheNeuralCloud.com

AI Meets Clinical Efficiency.
Faster Reports. Smarter Outcomes.

What We Do
CardioYield™ is AIML’s proprietary ECG reporting software, built to automate event labeling, interval calculation, and rhythm classification - powered by the MaxYield™ engine.

It integrates technician oversight with AI automation to produce Holter reports in a fraction of the time.

Why It Matters
Clinics face rising demand but limited staff. CardioYield™ increases throughput 3–5× using existing devices and teams, turning long review cycles into fast, scalable diagnostic reporting.

Designed with and for cardiac technologists, CardioYield turns Holter analysis from a labor intensive, manual process to a due diligence exercise on the events flagged. Built using AI & modern design, Validated by Experts.

Contact Us to Learn More

Visualize ECG Data with Custom Reports

What We Do
Insight360™ transforms raw ECG data into clear, actionable insights through advanced visualization, analytics, and customizable reporting tools. Turn complex signal data into interactive, easy-to-interpret dashboards.

Built for clinicians, researchers, and OEM partners, it integrates seamlessly with MaxYield™ outputs to display neuralized ECG metrics, HRV trends, and cardiac event timelines in one intuitive interface.



Why It Matters
Traditional ECG review tools are fragmented and data-dense. Insight360™ bridges this gap by providing a **single lens for cardiac insight**, transforming data into clarity. Enables faster, more confident decision-making - unlocking precision without complexity.

Whether reviewing one trace or an entire study, users see every heartbeat, interval, and anomaly - at a glance.


Coming soon...

Our flagship product CardioYield, powered by our proprietary and patent-pending MaxYield platform, is revolutionizing cardiovascular diagnostics by transforming raw ECG waveforms into precise, actionable insights.

Unlike traditional ECG analysis, which relies on static readings and manual interpretation, CardioYield leverages advanced AI-driven signal processing to extract a rich constellation of biomarkers from every heartbeat in real-time.

By seamlessly integrating with existing ECG devices, wearables, and digital health platforms, CardioYield empowers physicians, researchers, performance athletes, cardiac rehabilitation specialists  and healthcare educators with deeper diagnostic accuracy while giving individuals continuous access to their heart health data.

Built for scalability and global adoption, CardiYield powered by MaxYield  is setting a new standard in cardiovascular care—one where AI and biomedical intelligence converge to improve outcomes, prevent disease, and ultimately save lives.

Website launching June 30th, 2025